ブライトパス・バイオ 普通株式
Id | Date_of_disclosure | Date_of_calculation | Code_of_stock | Name_of_stock_jp | Name_of_stock_en | Name_of_short_seller | Address_of_short_seller | Name_of_discretionary_investment_contractor | Address_of_discretionary_investment_contractor | Name_of_investment_fund | Ratio_of_short_positions_to_shares_outstanding | Number_of_short_positions_in_shares | Number_of_short_positions_in_trading_units | Date_of_calculation_in_previous_reporting | Ratio_of_short_positions_in_previous_reporting | Notes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 186680 | 2024-04-02 | 2024-03-29 | 4594 | ブライトパス・バイオ 普通株式 | BrightPath Biotherapeutics Co.,Ltd. | XTX Markets Pte Ltd | 50, Collyer Quay, #06-05 OUE Bayfront, Singapore 049321 | nan | nan | nan | 0.0055 | 391900 | 3919 | 2024-03-27 | 0.0065 | nan |
| 185931 | 2024-04-03 | 2024-04-01 | 4594 | ブライトパス・バイオ 普通株式 | BrightPath Biotherapeutics Co.,Ltd. | MERRILL LYNCH INTERNATIONAL | 2 KING EDWARD STREET, LONDON, EC1A 1HQ | nan | nan | nan | 0.0053 | 364100 | 3641 | 2024-03-27 | 0.005 | nan |
| 185932 | 2024-04-03 | 2024-04-01 | 4594 | ブライトパス・バイオ 普通株式 | BrightPath Biotherapeutics Co.,Ltd. | UBS AG | Bahnhofstrasse 45, 8001 Zurich, Switzerland | nan | nan | nan | 0.0058 | 413100 | 4131 | 2024-03-26 | 0.006500000000000001 | nan |
| 185156 | 2024-04-04 | 2024-04-02 | 4594 | ブライトパス・バイオ 普通株式 | BrightPath Biotherapeutics Co.,Ltd. | MERRILL LYNCH INTERNATIONAL | 2 KING EDWARD STREET, LONDON, EC1A 1HQ | nan | nan | nan | 0.0059 | 407600 | 4076 | 2024-04-01 | 0.0053 | nan |
| 185157 | 2024-04-04 | 2024-04-02 | 4594 | ブライトパス・バイオ 普通株式 | BrightPath Biotherapeutics Co.,Ltd. | UBS AG | Bahnhofstrasse 45, 8001 Zurich, Switzerland | nan | nan | nan | 0.006 | 427800 | 4278 | 2024-04-01 | 0.0058 | nan |
| 184365 | 2024-04-05 | 2024-04-03 | 4594 | ブライトパス・バイオ 普通株式 | BrightPath Biotherapeutics Co.,Ltd. | Barclays Capital Securities Ltd | 5 The North Colonnade, Canary Wharf London E14 4BB, United Kingdom | nan | nan | nan | 0.009000000000000001 | 640600 | 6406 | 2024-03-18 | 0.0089 | nan |
| 184366 | 2024-04-05 | 2024-04-03 | 4594 | ブライトパス・バイオ 普通株式 | BrightPath Biotherapeutics Co.,Ltd. | MERRILL LYNCH INTERNATIONAL | 2 KING EDWARD STREET, LONDON, EC1A 1HQ | nan | nan | nan | 0.0066 | 451300 | 4513 | 2024-04-02 | 0.0059 | nan |
| 184367 | 2024-04-05 | 2024-04-03 | 4594 | ブライトパス・バイオ 普通株式 | BrightPath Biotherapeutics Co.,Ltd. | XTX Markets Pte Ltd | 50, Collyer Quay, #06-05 OUE Bayfront, Singapore 049321 | nan | nan | nan | 0.0064 | 458900 | 4589 | 2024-03-29 | 0.0055 | nan |
| 185158 | 2024-04-04 | 2024-04-03 | 4594 | ブライトパス・バイオ 普通株式 | BrightPath Biotherapeutics Co.,Ltd. | スパークス・アセット・マネジメント株式会社 | 東京都港区港南一丁目2番70号品川シーズンテラス | nan | nan | スパークス・シングル・レバレッジドL&Sマザーファンド | 0.0051 | 361300 | 3613 | 2024-03-15 | 0.0048 | nan |
| 183583 | 2024-04-08 | 2024-04-04 | 4594 | ブライトパス・バイオ 普通株式 | BrightPath Biotherapeutics Co.,Ltd. | Barclays Capital Securities Ltd | 5 The North Colonnade, Canary Wharf London E14 4BB, United Kingdom | nan | nan | nan | 0.0089 | 635400 | 6354 | 2024-04-03 | 0.009000000000000001 | nan |